Physician profile
Manuj C Singhal
NPI 1013133016
$39,057.10
in general payments reported to CMS, 2019-2025
13 companies · $4,243 in 2025
The $4,243 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $79.57 · 2021: $29K · 2022: $3,549 · 2024: $242 · 2025: $4,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,100 · Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,100.00 |
| Food and Beverage | $384.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $25,210.47 | 2020-2021 | |
| Pylant Medical | $5,368.22 | 2019-2022 | |
| Fidia Pharma USA INC. | $4,141.97 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Arthrex, INC. | $3,803.36 | 2021-2022 | |
| Miach Orthopaedics, INC. | $175.90 | 2024 | |
| Vericel Corporation | $116.79 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $87.40 | 2019-2025 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $58.49 | 2020-2025 | Na, Monovisc |
| Ferring Pharmaceuticals INC. | $30.88 | 2022 | |
| Medtronic, INC. | $17.10 | 2022 | |
| Ossur Americas, INC. | $16.90 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $15.70 | 2025 | |
| Smith+Nephew, INC. | $13.92 | 2024 | Bone Anchors With Arthroscopic Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuj Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.